Thermo Fisher Scientific Inc. (TMO): Among Billionaire Quants' Two Sigma's Stock Picks with Huge Upside Potential
We recently published a list of . In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other billionaire quants' two sigma's stock picks with huge upside potential.
is one of the leading players in the quantitative hedge fund space, according to Archive Market Research's analysis. The quant fund operates as an investment management company and was founded in 2001 by David Siegel, a computer scientist, and John Overdeck, a mathematician. The fund manages $60 billion worth of assets as of April 2025.
Quant funds and their multi-strategy counterparts often do well in the market. A Reuters analysis found that many quant hedge funds posted double-digit growth in 2024. This growth happened despite 'negative drivers' in sectors like energy, metals, and European equities. Two Sigma, alongside quant funds like D.E. Shaw and Citadel, also managed solid performance last year.
The hedge fund's Spectrum Fund returned 10.9% and 14.3% for the Absolute Return Enhanced Fund. But one might argue that for a hedge fund that relies on complex algorithms to make investment decisions, the asset manager should have beat the market. For context, the S&P 500 finished 2024 with a total gain of 25.0%.
READ ALSO: Billionaire Ray Dalio's Bridgewater's 10 Stock Picks with Huge Upside Potential and Billionaire Mario Gabelli's 10 Large-Cap Stock Picks with Huge Upside Potential.
In August last year, the billionaire founders of the hedge fund exited from active management because they couldn't resolve tension between them.
'Over the past year and a half, we and our senior management team have dedicated significant effort to securing the long-term success and stability of Two Sigma. Throughout this process, our own roles have been a central consideration. Today, we are confident that stepping back from our day-to-day management roles is the right decision at this time,' the co-founders said in a letter to investors.
But recent reports indicate that Overdeck is returning to active management. 'John has determined now is the right time for him to return to this role in order to progress certain priorities and decisions he believes are important to the future of Two Sigma,' Two Sigma said in a letter. Siegel chose to remain outside of the fund's top ranks but had 'full confidence' in Scott Hoffman, one of the Co-CEOs who took over last year.
It is good news that Two Sigma won't be held back by feuding management because they need it to navigate a challenging market. According to a Reuters analysis, the risk of recession is alarming, even though it may not be as clear-cut. The report quoted Zurich Insurance Group's chief market strategist, Guy Miller, who said that the risk of a US recession is quite plausible. 'Recession risks have risen markedly even if there are some deals struck on tariffs. The risk of a U.S. recession is 50-50, it's that close.'
We sifted through Two Sigma Advisors' SEC Q4 2024 13F filings to create this list. We primarily targeted the fund's most valuable equity holdings (excluding ETFs and options) and then ranked the picks based on analyst price targets as of May 8, 2025. We picked stocks with an upside potential of at least 30% and then selected the top 10. We have also added the broader hedge fund sentiment for the stocks, as of Q4 2024.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A workstation in a research lab stocked with laboratory products and services.Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in scientific research and laboratory solutions. It provides tools, technologies, and services to help scientists, healthcare professionals, and businesses advance discoveries and improve lives.
The company has recently made several moves to strengthen its market position. On April 24, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) announced a $2 billion investment in the US over the next four years. The first $1.5 billion will be allocated to capital expenditures for enhancing and expanding US manufacturing operations, and $500 million will go to R&D focused on high-impact innovation. This investment builds on the company's substantial presence in US manufacturing, which already includes 64 operations across 37 states. On April 28, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) introduced an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months. The solution helps biotech and pharmaceutical companies overcome logistical complexities in pre-clinical biologic drug development.
The company has also taken some cost-cutting measures. On May 3, 2025, Thermo Fisher (NYSE:TMO) announced it would close its location near downtown Orlando and lay off 58 employees. The move will primarily affect researchers, nurses, and staff tied to its PPD Clinical Research Services division. On April 25, Scotiabank analyst Sung Ji Nam adjusted the price target for Thermo Fisher Scientific Inc. (NYSE:TMO) to $605 from $650. Nam wrote that although the company surpassed expectations in its first quarter results of 2025, it revised the full-year guidance. Nevertheless, Nam maintained a Sector Perform rating.
Overall, TMO ranks 5th on our list of billionaire quants' two sigma's stock picks with huge upside potential. While we acknowledge the potential of TMO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than TMO but that trades at less than 5 times its earnings check out our report about this
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
23 minutes ago
- Business Insider
Morgan Stanley shares a chart that fuels the argument for new stock-market highs
Morgan Stanley is growing more optimistic about the stock market as earnings revisions breadth improves. Improving breadth is being driven by more upward revisions, the bank said. The market is likely to overlook softer hard data in favor of forward-looking views of strong earnings. The vibes in the stock market are improving, and it's boosting the case for prices to rise from here. That's according to a note from Morgan Stanley's Mike Wilson. The bank's CIO and chief stock strategist pointed to a key signal that's sending a bullish signal: a sharp rebound in earnings revisions breadth, or the proportion of analysts who have raised their estimates minus the proportion who have lowered them. The indicator is now at -10%, a noticeable improvement from -25% during the height of tariff uncertainty in April, an indication that sentiment is recovering. The bank believes the indicator will continue to trend upward. A weak dollar could further bolster this earnings gauge, as US companies that do a lot of business overseas receive a boost in sales when the dollar is weaker. Once earnings revisions breadth turns positive, investors should expect forward EPS predictions to trend higher. Earnings revision breadth can be driven by either fewer downward revisions or more upward revisions. According to Morgan Stanley, the latter is the case today, which is good news for investors. More upward revisions tend to result in stronger overall stock market performance, historically leading to a 13% increase in the S&P 500 over a 12-month span. When fewer downward revisions are the driving factor, the S&P 500 has historically returned 8% over the next 12 months. Morgan Stanley's 12-month price target for the S&P 500 is 6,500, a potential gain of 8% from current levels. Investors should pay more attention to the improvement in forward-looking earnings revision breadth rather than lagging hard data, according to Morgan Stanley. The bank sees April stock market lows as the end of a year-long trend of downward earnings revisions, and expects the rate of change on earnings revision breadth to be the primary driver of equity prices going forward. "In our experience, when revisions breadth is accelerating in a V-shaped manner from an extreme low, equity markets typically remain supported and pullbacks remain shallow and unsatisfying (like the past 6 weeks)," Wilson wrote. The recent outperformance of cyclical stocks also points to a market more focused on forward-looking earnings revisions than backward-looking hard data. These areas of the market are especially sensitive to economic growth and earnings, and they're picking up momentum and providing a tailwind to the overall stock market. While it's possible that inflation could creep up over the summer as the pull-forward effect of tariffs fades, Morgan Stanley believes the bulk of the tariff pain appears to be already priced in following the April 2 tariff announcements. Policy headwinds should ease soon, as Trump's term began by front-loading disruptive tariff policies and will transition to more pro-growth initiatives like deregulation and tax cuts. Over the last month, the market has has rallied over 20% from April lows despite a first quarter GDP contraction weakening manufacturing data. As long as earnings revisions breadth continues trending upwards, Morgan Stanley believes the stock market will continue to overlook short term weakness in hard data.
Yahoo
33 minutes ago
- Yahoo
The bull case for stocks is growing among Wall Street strategists
Wall Street strategists aren't scared of a summer slowdown for stocks despite some indications of a cooling labor market and slowing economic activity. In the past month, several strategists have defended their S&P 500 year-end targets in the range of 6,300 to 6,500, noting that the most dire outcomes from tariffs may no longer be on the table. On Monday, the benchmark index was trading around 6,010, about 2% from the record closing high. In a note titled "Don't fight it," Morgan Stanley chief investment officer Mike Wilson pointed out that a "moderate slowdown in growth" was likely already priced in earlier this year when the average S&P 500 stock fell nearly 30%. "In our experience, stocks and equity market internals move well ahead of lagging economic data and earnings results," Wilson said. To be clear, there are certainly signs of softening in economic data. Last week, ADP data showed that the private sector added 37,000 jobs in May, the lowest monthly total in more than two years. Weekly filings for unemployment claims hit their highest level since October 2024. And monthly nonfarm payroll revisions revealed 95,000 fewer jobs were added in March and April than initially thought. But the slowdown in this data has been widely expected. The equity research team at Goldman Sachs analyzed prior "event driven recessions" such as the bursting of the dot-com bubble and the 1970s interest rate shock. Goldman's team, led by chief US equity strategist David Kostin, found that so-called soft economic data, which encapsulates data points like consumer surveys, usually hits its cycle bottom before hard economic data, like monthly readings on inflation or job additions, does. That's been playing out over the past month. In May, the Conference Board's future expectations index saw its largest monthly increase since May 2009. But data on Monday showed inflation expectations in the New York Federal Reserve's monthly survey moved lower in May for the first time this year, perhaps marking that the worst tariff-driven inflation fears might be behind markets too. Read more: How to protect your savings against inflation Kostin's work shows the S&P 500 typically will follow the soft data's return higher, even if hard economic data, like monthly jobs reports, continues to move lower. "S&P 500 returns are currently more correlated with soft data than hard data," wrote Kostin, who projects the S&P 500 will hit 6,500 in the next 12 months. "If the recovery in soft data is sustained, it should support equity returns even as hard data weaken." Citi equity strategist Scott Chronert boosted his S&P 500 target to 6,300 on Monday from a prior forecast of 5,800. Chronert, like other strategists, pointed out that peak tariff uncertainty has likely passed following the pause on duties between the US and China. With that headwind easing, Chronert pointed out that economic growth forecasts are no longer falling either. After tumbling to a recent bottom of 1.35% in early May, consensus is now projecting the US economy to grow at an annualized pace of 1.4% in 2025. Chronert and other strategists agree that the key risk moving forward would be that economic growth data slows more than consensus is now expecting. But barring that outcome, Chronert likes growth stocks such as Big Tech names amid a market environment that features elevated interest rates and high stock valuations. "Our growth preference continues for now as the AI theme regains momentum," Chronert wrote. Josh Schafer is a reporter for Yahoo Finance. Follow him on X @_joshschafer. Sign in to access your portfolio
Yahoo
43 minutes ago
- Yahoo
India faces two years of sugar surplus, growers and officials say
By Rajendra Jadhav SATARA, India (Reuters) -India is set to produce surplus sugar for at least two consecutive years, as millions of farmers expand the area under sugarcane cultivation amid ample rainfall, boosting crop yields, growers and industry officials said. The rebound in production would allow the world's second-largest sugar producer to increase exports in 2025/26, they said, after poor rainfall cut sugarcane yields and led to two years of export restrictions. "Sugarcane usually gives us good returns, but sometimes we can't plant it due to a lack of water," said Umesh Jagtap as he planted the crop on a three-acre plot in Maharashtra, a leading sugar producing state in the west. "This year, we had heavy rain in May, and the forecast says more rain is on the way. So we're planning to plant more than usual." Farmers from Maharashtra and neighbouring Karnataka struggle to irrigate their sugarcane crop in May. This year, however, Maharashtra and Karnataka received 1,007% and 234% more rainfall than average, respectively. The rainfall will benefit the crop to be harvested in the 2025/26 season, starting October, and will also support planting for the 2026/27 harvest, said Prakash Naiknavare, managing director of the National Federation of Cooperative Sugar Factories (NFCSF). Sugarcane typically takes 10 to 18 months from planting to harvest. As a result, farmers who began planting this month are expected to harvest their crop during the 2026/27 season. The NFCSF estimates gross sugar production in 2025/26 to rise by nearly a fifth from a year earlier, reaching 35 million metric tons. For the 2024/25 marketing year to September, India's net sugar production is expected to fall below consumption for the first time in eight years. This decline stems from a 2023 drought that hit sugarcane planting and forced India to prohibit sugar exports in 2023/24 and allowing merely 1 million tons in 2024/25. India was the world's No. 2 sugar exporter during the five years to 2022/23, with volumes averaging 6.8 million tons annually. "Looks like production is set to bounce back strongly, so New Delhi will probably have no trouble allowing exports of over 3 million tons in the next season starting October," said a Mumbai-based trader with a global trade house.
